Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.28 | ug/ml | 12932143 |
NPT88 | Organism | Mycobacterium tuberculosis | Mycobacterium tuberculosis | MIC | = | 3940 | nM | DrugMatrix in vivo data: Pathology |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.67 | ug/ml | 21448090 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC81006 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9737 | High Similarity | NPC31313 |
0.9737 | High Similarity | NPC288415 |
0.9737 | High Similarity | NPC149908 |
0.9737 | High Similarity | NPC45906 |
0.961 | High Similarity | NPC93630 |
0.8974 | High Similarity | NPC90839 |
0.8421 | Intermediate Similarity | NPC255050 |
0.8421 | Intermediate Similarity | NPC127553 |
0.6596 | Remote Similarity | NPC168017 |
0.6582 | Remote Similarity | NPC112398 |
0.6522 | Remote Similarity | NPC124359 |
0.6458 | Remote Similarity | NPC178632 |
0.6196 | Remote Similarity | NPC471420 |
0.6145 | Remote Similarity | NPC233034 |
0.6118 | Remote Similarity | NPC126664 |
0.6118 | Remote Similarity | NPC34291 |
0.6078 | Remote Similarity | NPC313821 |
0.6024 | Remote Similarity | NPC163134 |
0.6024 | Remote Similarity | NPC471419 |
0.6 | Remote Similarity | NPC477002 |
0.5978 | Remote Similarity | NPC150557 |
0.5909 | Remote Similarity | NPC476695 |
0.5909 | Remote Similarity | NPC476694 |
0.5909 | Remote Similarity | NPC476696 |
0.5882 | Remote Similarity | NPC238646 |
0.5859 | Remote Similarity | NPC470284 |
0.5794 | Remote Similarity | NPC314387 |
0.5758 | Remote Similarity | NPC470282 |
0.5755 | Remote Similarity | NPC56298 |
0.5755 | Remote Similarity | NPC471628 |
0.5747 | Remote Similarity | NPC471418 |
0.5747 | Remote Similarity | NPC474469 |
0.5732 | Remote Similarity | NPC471421 |
0.5732 | Remote Similarity | NPC233364 |
0.5714 | Remote Similarity | NPC91036 |
0.5682 | Remote Similarity | NPC475127 |
0.5682 | Remote Similarity | NPC475715 |
0.5682 | Remote Similarity | NPC473419 |
0.5682 | Remote Similarity | NPC268922 |
0.5679 | Remote Similarity | NPC293551 |
0.5673 | Remote Similarity | NPC119225 |
0.5673 | Remote Similarity | NPC470382 |
0.5673 | Remote Similarity | NPC476261 |
0.5673 | Remote Similarity | NPC471635 |
0.5673 | Remote Similarity | NPC25033 |
0.566 | Remote Similarity | NPC220111 |
0.5641 | Remote Similarity | NPC475887 |
0.5632 | Remote Similarity | NPC184150 |
0.5632 | Remote Similarity | NPC141156 |
0.5625 | Remote Similarity | NPC36927 |
0.5625 | Remote Similarity | NPC271772 |
0.5607 | Remote Similarity | NPC315036 |
0.5604 | Remote Similarity | NPC315806 |
0.56 | Remote Similarity | NPC52533 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC81006 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.6168 | Remote Similarity | NPD8140 | Approved |
0.6145 | Remote Similarity | NPD9440 | Discontinued |
0.6118 | Remote Similarity | NPD9443 | Clinical (unspecified phase) |
0.6087 | Remote Similarity | NPD8347 | Approved |
0.6087 | Remote Similarity | NPD8345 | Approved |
0.6087 | Remote Similarity | NPD8346 | Approved |
0.6078 | Remote Similarity | NPD3190 | Approved |
0.6078 | Remote Similarity | NPD3189 | Approved |
0.6078 | Remote Similarity | NPD3191 | Approved |
0.6019 | Remote Similarity | NPD8307 | Discontinued |
0.5895 | Remote Similarity | NPD882 | Phase 2 |
0.5895 | Remote Similarity | NPD883 | Phase 2 |
0.5872 | Remote Similarity | NPD7646 | Clinical (unspecified phase) |
0.5854 | Remote Similarity | NPD9455 | Approved |
0.5794 | Remote Similarity | NPD3183 | Approved |
0.5794 | Remote Similarity | NPD3184 | Approved |
0.5794 | Remote Similarity | NPD3182 | Approved |
0.5794 | Remote Similarity | NPD3185 | Approved |
0.5783 | Remote Similarity | NPD393 | Approved |
0.5755 | Remote Similarity | NPD4837 | Approved |
0.5755 | Remote Similarity | NPD4835 | Approved |
0.5755 | Remote Similarity | NPD4838 | Approved |
0.5755 | Remote Similarity | NPD4836 | Approved |
0.573 | Remote Similarity | NPD7535 | Discontinued |
0.5714 | Remote Similarity | NPD8087 | Discontinued |
0.5699 | Remote Similarity | NPD8143 | Approved |
0.5699 | Remote Similarity | NPD8144 | Approved |
0.5641 | Remote Similarity | NPD7348 | Clinical (unspecified phase) |
0.5625 | Remote Similarity | NPD2691 | Clinical (unspecified phase) |
0.5604 | Remote Similarity | NPD9653 | Clinical (unspecified phase) |
PubChem CID   | 5276744 |
ChEMBL   | CHEMBL518547 |
ZINC   |
Molecular Weight:   | 478.38 |
ALogP:   | -4.5718 |
MLogP:   | 3.88 |
XLogP:   | 4.84 |
# Rotatable Bonds:   | 2 |
Polar Surface Area:   | 65.4 |
# H-Bond Aceptor:   | 6 |
# H-Bond Donor:   | 2 |
# Rings:   | 5 |
# Heavy Atoms:   | 34 |